Concerns rise among Korean drug makers

The domestic pharmaceutical sector is expected to face an inevitable blow with major drug companies from the United States taking a stronger hold of the local market following the Korea-US free trade agreement.

Under the agreement, U.S. drug makers will be able to secure longer exclusive sales periods for their products in Korea. They will also have more control when determining the price of...